242 related articles for article (PubMed ID: 12818179)
1. RGS9 modulates dopamine signaling in the basal ganglia.
Rahman Z; Schwarz J; Gold SJ; Zachariou V; Wein MN; Choi KH; Kovoor A; Chen CK; DiLeone RJ; Schwarz SC; Selley DE; Sim-Selley LJ; Barrot M; Luedtke RR; Self D; Neve RL; Lester HA; Simon MI; Nestler EJ
Neuron; 2003 Jun; 38(6):941-52. PubMed ID: 12818179
[TBL] [Abstract][Full Text] [Related]
2. D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
Kovoor A; Seyffarth P; Ebert J; Barghshoon S; Chen CK; Schwarz S; Axelrod JD; Cheyette BN; Simon MI; Lester HA; Schwarz J
J Neurosci; 2005 Feb; 25(8):2157-65. PubMed ID: 15728856
[TBL] [Abstract][Full Text] [Related]
3. Effects of gender on locomotor sensitivity to amphetamine, body weight, and fat mass in regulator of G protein signaling 9 (RGS9) knockout mice.
Walker PD; Jarosz PA; Bouhamdan M; MacKenzie RG
Physiol Behav; 2015 Jan; 138():305-12. PubMed ID: 25455864
[TBL] [Abstract][Full Text] [Related]
4. R7BP complexes with RGS9-2 and RGS7 in the striatum differentially control motor learning and locomotor responses to cocaine.
Anderson GR; Cao Y; Davidson S; Truong HV; Pravetoni M; Thomas MJ; Wickman K; Giesler GJ; Martemyanov KA
Neuropsychopharmacology; 2010 Mar; 35(4):1040-50. PubMed ID: 20043004
[TBL] [Abstract][Full Text] [Related]
5. Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.
Gross JD; Kaski SW; Schroer AB; Wix KA; Siderovski DP; Setola V
J Psychopharmacol; 2018 Feb; 32(2):191-203. PubMed ID: 29364035
[TBL] [Abstract][Full Text] [Related]
6. RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons.
Cabrera-Vera TM; Hernandez S; Earls LR; Medkova M; Sundgren-Andersson AK; Surmeier DJ; Hamm HE
Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16339-44. PubMed ID: 15534226
[TBL] [Abstract][Full Text] [Related]
7. Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.
Gaspari S; Papachatzaki MM; Koo JW; Carr FB; Tsimpanouli ME; Stergiou E; Bagot RC; Ferguson D; Mouzon E; Chakravarty S; Deisseroth K; Lobo MK; Zachariou V
Neuropsychopharmacology; 2014 Jul; 39(8):1968-77. PubMed ID: 24561386
[TBL] [Abstract][Full Text] [Related]
8. Gating properties of GIRK channels activated by Galpha(o)- and Galpha(i)-coupled muscarinic m2 receptors in Xenopus oocytes: the role of receptor precoupling in RGS modulation.
Zhang Q; Pacheco MA; Doupnik CA
J Physiol; 2002 Dec; 545(2):355-73. PubMed ID: 12456817
[TBL] [Abstract][Full Text] [Related]
9. Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum.
Song C; Anderson GR; Sutton LP; Dao M; Martemyanov KA
J Neurosci; 2018 Aug; 38(32):7120-7131. PubMed ID: 30006367
[TBL] [Abstract][Full Text] [Related]
10. Measuring the modulatory effects of RGS proteins on GIRK channels.
Doupnik CA; Jaén C; Zhang Q
Methods Enzymol; 2004; 389():131-54. PubMed ID: 15313564
[TBL] [Abstract][Full Text] [Related]
11. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
[TBL] [Abstract][Full Text] [Related]
12. RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors.
Celver J; Sharma M; Kovoor A
J Neurochem; 2010 Aug; 114(3):739-49. PubMed ID: 20477943
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of ERbeta and RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior.
Silverman JL; Koenig JI
Horm Behav; 2007 Aug; 52(2):146-55. PubMed ID: 17493623
[TBL] [Abstract][Full Text] [Related]
14. From molecules to behavior: new clues for RGS function in the striatum.
Burns ME; Wensel TG
Neuron; 2003 Jun; 38(6):853-6. PubMed ID: 12818171
[TBL] [Abstract][Full Text] [Related]
15. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions.
Taymans JM; Leysen JE; Langlois X
J Neurochem; 2003 Mar; 84(5):1118-27. PubMed ID: 12603835
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
Gong W; Neill DB; Lynn M; Justice JB
Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
[TBL] [Abstract][Full Text] [Related]
17. Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts.
Stanwood GD; Parlaman JP; Levitt P
Eur J Neurosci; 2006 Aug; 24(3):806-18. PubMed ID: 16930410
[TBL] [Abstract][Full Text] [Related]
18. A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.
Psifogeorgou K; Terzi D; Papachatzaki MM; Varidaki A; Ferguson D; Gold SJ; Zachariou V
J Neurosci; 2011 Apr; 31(15):5617-24. PubMed ID: 21490202
[TBL] [Abstract][Full Text] [Related]
19. RGS9-2: probing an intracellular modulator of behavior as a drug target.
Traynor JR; Terzi D; Caldarone BJ; Zachariou V
Trends Pharmacol Sci; 2009 Mar; 30(3):105-11. PubMed ID: 19211160
[TBL] [Abstract][Full Text] [Related]
20. Repeated intravenous cocaine administration: locomotor activity and dopamine D2/D3 receptors.
Wallace DR; Mactutus CF; Booze RM
Synapse; 1996 Jul; 23(3):152-63. PubMed ID: 8807743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
